The description of the applicant's pharmacovigilance system, which is used by the applicant in relation to one or more medicinal products, vaccines, tuberculin, is provided in the pharmacovigilance system master file (PSMF). This document is compiled in accordance with the structure given in Annex 11 to the Procedure for pharmacovigilance (as amended by the MoH order of 26 September 2016 No. 996), and contains information on:
1 the applicant's qualified person responsible for pharmacovigilance and/or the contact person responsible for pharmacovigilance;
2) the organizational structure of the applicant, including a pharmacovigilance system that ensures the collection, identification, evaluation and submission of reliable information on adverse reactions, lack of efficacy, SUI, as well as any other data necessary for assessing the risk and benefit of the use of a medicinal product, vaccine, tuberculin;
3) natural and/or legal persons engaged by the applicant to carry out pharmacovigilance;
4) sources of information on the safety of the use of medicinal products, vaccines, tuberculin;
5) a list and brief functional description of the databases used by the applicant in carrying out pharmacovigilance;
6) pharmacovigilance processes, including a list of standard operating procedures used in carrying out pharmacovigilance, a description of pharmacovigilance documentation, including documentation kept in the archive, and other types of documentation relating to the carrying out of pharmacovigilance;
7) the effectiveness of the pharmacovigilance system;
8) a quality system in pharmacovigilance, including a description of the applicant's personnel training system, indicating information about training, taking into account the functional duties of the applicant's personnel, and providing a concise description of the applicant's obligations to ensure the quality of the pharmacovigilance system audit, including an audit of the pharmacovigilance system and an audit of the natural and/or legal persons engaged by the applicant to carry out pharmacovigilance.
Regulatory references: subparagraph 1 of paragraph 2 of chapter 1 of section V of the Procedure for Pharmacovigilance, approved by order of the Ministry of Health of Ukraine of 27 December 2006 No. 898, registered with the Ministry of Justice of Ukraine on 19 December 2016 under No. 1649/29779 (as amended by order of the Ministry of Health of Ukraine of 26 September 2016 No. 996).